NCT01431300View on ClinicalTrials.gov

Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants

NACompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2013

Conditions

Healthy

Interventions

DRUG

gadofosveset

Intravenous administration of the specified dosage of gadolinium contrast agent

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Lantheus Medical Imaging

All Listed Sponsors

collaborator

Lantheus Medical Imaging

INDUSTRY

lead

Duke University

OTHER